M. Jafri, J. Whitworth, E. Rattenberry, L. Vialard, and G. Kilby, Evaluation of SDHB, SDHD and VHL gene susceptibility testing in the assessment of individuals with non-syndromic phaeochromocytoma, paraganglioma and head and neck paraganglioma, Clinical Endocrinology, vol.31, issue.6, pp.898-906, 2013.
DOI : 10.1002/humu.21269

V. Piccini, E. Rapizzi, A. Bacca, D. Trapani, G. Pulli et al., Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients, Endocrine Related Cancer, vol.19, issue.2, pp.149-155, 2012.
DOI : 10.1530/ERC-11-0369

URL : http://erc.endocrinology-journals.org/content/19/2/149.full.pdf

H. Timmers, A. Gimenez-roqueplo, M. Mannelli, and K. Pacak, Clinical aspects of SDHx-related pheochromocytoma and paraganglioma, Endocrine Related Cancer, vol.16, issue.2, pp.391-400, 2009.
DOI : 10.1677/ERC-08-0284

H. Huang, J. Abraham, E. Hung, S. Averbuch, and M. Merino, Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine, Cancer, vol.24, issue.8, pp.2020-2028, 2008.
DOI : 10.1007/BF03345807

J. Isaacs, Y. Jung, D. Mole, S. Lee, and C. Torres-cabala, HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability, Cancer Cell, vol.8, issue.2, pp.143-153, 2005.
DOI : 10.1016/j.ccr.2005.06.017

L. Dang, D. White, S. Gross, B. Bennett, and M. Bittinger, Cancer-associated IDH1 mutations produce 2-hydroxyglutarate, Nature, vol.50, issue.7274, pp.739-744, 2009.
DOI : 10.1038/nature08617

W. Kaelin, . Jr, and S. Mcknight, Influence of Metabolism on Epigenetics and Disease, Cell, vol.153, issue.1, pp.56-69, 2013.
DOI : 10.1016/j.cell.2013.03.004

E. Letouze, C. Martinelli, C. Loriot, N. Burnichon, and N. Abermil, SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma, Cancer Cell, vol.23, issue.6, pp.739-752, 2013.
DOI : 10.1016/j.ccr.2013.04.018

P. Pollard, J. Briere, N. Alam, J. Barwell, and E. Barclay, Accumulation of Krebs cycle intermediates and over-expression of HIF1?? in tumours which result from germline FH and SDH mutations, Human Molecular Genetics, vol.14, issue.15, pp.2231-2239, 2005.
DOI : 10.1042/bj20031647

M. Xiao, H. Yang, W. Xu, S. Ma, and H. Lin, Inhibition of ??-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors, Genes & Development, vol.26, issue.12, pp.1326-1338, 2012.
DOI : 10.1101/gad.191056.112

D. Wishart, Exploring the Human Metabolome by Nuclear Magnetic Resonance Spectroscopy and Mass Spectrometry, 2013.
DOI : 10.1017/CBO9780511996634.002

W. Pope, R. Prins, A. Thomas, M. Nagarajan, R. Yen et al., Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy, Journal of Neuro-Oncology, vol.19, issue.1, pp.197-205, 2012.
DOI : 10.1016/j.ccr.2010.12.014

M. Piotto, F. Moussallieh, A. Imperiale, M. Benahmed, and J. Detour, Reproducible Sample Preparation and Spectrum Acquisition Techniques for Metabolic Profiling of Human Tissues by Proton High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance, 2013.
DOI : 10.1017/CBO9780511996634.027

S. Meiboom and D. Gill, Modified Spin???Echo Method for Measuring Nuclear Relaxation Times, Review of Scientific Instruments, vol.233, issue.8, pp.688-691, 1958.
DOI : 10.1103/RevModPhys.26.167

M. Martinez-bisbal, L. Marti-bonmati, J. Piquer, A. Revert, and P. Ferrer, 1H and13C HR-MAS spectroscopy of intact biopsy samplesex vivo andin vivo1H MRS study of human high grade gliomas, NMR in Biomedicine, vol.17, issue.4, pp.191-205, 2004.
DOI : 10.1002/nbm.888

D. Wishart, D. Tzur, C. Knox, R. Eisner, and A. Guo, HMDB: the Human Metabolome Database, Nucleic Acids Research, vol.35, issue.Database, pp.521-526, 2007.
DOI : 10.1093/nar/gkl923

URL : https://academic.oup.com/nar/article-pdf/35/suppl_1/D521/3870909/gkl923.pdf

J. Rao, U. Engelke, R. Rodenburg, R. Wevers, and K. Pacak, Genotype-Specific Abnormalities in Mitochondrial Function Associate with Distinct Profiles of Energy Metabolism and Catecholamine Content in Pheochromocytoma and Paraganglioma, Clinical Cancer Research, vol.19, issue.14, pp.3787-3795, 2013.
DOI : 10.1158/1078-0432.CCR-12-3922

O. Beckonert, M. Coen, H. Keun, Y. Wang, and T. Ebbels, High-resolution magic-angle-spinning NMR spectroscopy for metabolic profiling of intact tissues, Nature Protocols, vol.112, issue.6, pp.1019-1032, 2010.
DOI : 10.1111/j.1471-4159.1981.tb01608.x

B. Sitter, T. Bathen, M. Tessem, and I. Gribbestad, High-resolution magic angle spinning (HR MAS) MR spectroscopy in metabolic characterization of human cancer, Progress in Nuclear Magnetic Resonance Spectroscopy, vol.54, issue.3-4, pp.239-254, 2009.
DOI : 10.1016/j.pnmrs.2008.10.001

T. Ebbels and R. Cavill, Bioinformatic methods in NMR-based metabolic profiling, Progress in Nuclear Magnetic Resonance Spectroscopy, vol.55, issue.4, pp.361-374, 2009.
DOI : 10.1016/j.pnmrs.2009.07.003

R. Picard and R. Cook, Cross-Validation of Regression Models, Journal of the American Statistical Association, vol.9, issue.387, pp.575-583, 1984.
DOI : 10.1080/00401706.1977.10489581

Q. Xu and Y. Liang, Monte Carlo cross validation, Chemometrics and Intelligent Laboratory Systems, vol.56, issue.1, pp.1-11, 2001.
DOI : 10.1016/S0169-7439(00)00122-2

D. Wishart, T. Jewison, A. Guo, M. Wilson, and C. Knox, HMDB 3.0???The Human Metabolome Database in 2013, Nucleic Acids Research, vol.8, issue.D1, pp.801-807, 2013.
DOI : 10.1002/pmic.200890049

URL : https://academic.oup.com/nar/article-pdf/35/suppl_1/D521/3870909/gkl923.pdf

A. Imperiale, K. Elbayed, F. Moussallieh, N. Reix, and M. Piotto, Metabolomic profile of the adrenal gland: from physiology to pathological conditions, Endocrine Related Cancer, vol.20, issue.5, pp.705-716, 2013.
DOI : 10.1530/ERC-13-0232

J. Favier, J. Briere, N. Burnichon, J. Riviere, and L. Vescovo, The Warburg Effect Is Genetically Determined in Inherited Pheochromocytomas, PLoS ONE, vol.4, issue.9, p.7094, 2009.
DOI : 10.1371/journal.pone.0007094.t003

R. Feichtinger, F. Zimmermann, J. Mayr, D. Neureiter, and M. Ratschek, Alterations of respiratory chain complexes in sporadic pheochromocytoma, Frontiers in bioscience, vol.3, pp.194-200, 2011.

Z. Reitman, J. G. Karoly, E. Spasojevic, I. Yang, and J. , Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome, Proceedings of the National Academy of Sciences, vol.16, issue.1, pp.3270-3275, 2011.
DOI : 10.1046/j.1460-9568.2002.02055.x

F. Van-nederveen, J. Gaal, J. Favier, E. Korpershoek, and R. Oldenburg, An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis, The Lancet Oncology, vol.10, issue.8, pp.764-771, 2009.
DOI : 10.1016/S1470-2045(09)70164-0

A. Gill, D. Benn, A. Chou, A. Clarkson, and A. Muljono, Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes, Human Pathology, vol.41, issue.6, pp.805-814, 2010.
DOI : 10.1016/j.humpath.2009.12.005

E. Korpershoek, J. Favier, J. Gaal, N. Burnichon, and B. Van-gessel, Gene Mutations in Apparently Sporadic Paragangliomas and Pheochromocytomas, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.9, pp.1472-1476, 2011.
DOI : 10.1210/jc.2011-1043

URL : https://academic.oup.com/jcem/article-pdf/96/9/E1472/10412793/jcem1472.pdf

G. Eisenhofer, J. Lenders, W. Linehan, M. Walther, and D. Goldstein, Plasma Normetanephrine and Metanephrine for Detecting Pheochromocytoma in von Hippel???Lindau Disease and Multiple Endocrine Neoplasia Type 2, New England Journal of Medicine, vol.340, issue.24, pp.1872-1879, 1999.
DOI : 10.1056/NEJM199906173402404

G. Eisenhofer, K. Pacak, T. Huynh, N. Qin, and G. Bratslavsky, Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma, Endocrine Related Cancer, vol.18, issue.1, pp.97-111, 2011.
DOI : 10.1677/ERC-10-0211

URL : http://erc.endocrinology-journals.org/content/18/1/97.full.pdf

G. Eisenhofer, M. Walther, T. Huynh, S. Li, and S. Bornstein, Pheochromocytomas in von Hippel-Lindau Syndrome and Multiple Endocrine Neoplasia Type 2 Display Distinct Biochemical and Clinical Phenotypes, The Journal of Clinical Endocrinology & Metabolism, vol.86, issue.5, pp.1999-2008, 2001.
DOI : 10.1210/jcem.86.5.7496

N. Burnichon, A. Cascon, F. Schiavi, N. Morales, and I. Comino-mendez, MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma, Clinical Cancer Research, vol.18, issue.10, pp.2828-2837, 2012.
DOI : 10.1158/1078-0432.CCR-12-0160

URL : https://hal.archives-ouvertes.fr/hal-01048691

M. Yang and P. Pollard, Succinate: A New Epigenetic Hacker, Cancer Cell, vol.23, issue.6, pp.709-711, 2013.
DOI : 10.1016/j.ccr.2013.05.015

URL : https://doi.org/10.1016/j.ccr.2013.05.015

D. Burgess, Epigenetic links to the web of Krebs, Nature Reviews Cancer, vol.3, issue.7, p.437, 2013.
DOI : 10.1158/2159-8290.CD-13-0092